Prior Auth Required

0179U - partner/breakpoint, copy number variations), with report of significant mutation(s)

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Servicepartner/breakpoint, copy number variations), with report of significant mutation(s)
Procedure / Service Description

Targeted genomic sequence analysis panel, acute myeloid leukemia, myelodysplastic - Oncology (non-small cell lung cancer), cell-free DNA, targeted sequence analysis of 23 genes (single nucleotide variations, insertions and deletions, fusions without prior knowledge of 0179U partner/breakpoint, copy number variations), with report of significant mutation(s) 0182T High dose rate electronic brachytherapy, per fraction Low frequency, non-contact, non-thermal ultrasound, including topical application(s), when

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.